| 1 |
33524967 | One step assembly of ginsenoside Rb1-based nanovehicles with fast cellular transport in photothermal-chemical combined cancer therapy. | 2021 May 7 |
1 |
| 2 |
30005287 | Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery. | 2018 Nov 1 |
1 |
| 3 |
28580174 | Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines. | 2017 |
4 |
| 4 |
26004085 | Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. | 2015 Oct |
1 |
| 5 |
23462184 | CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage. | 2013 Apr 1 |
2 |
| 6 |
23859194 | Mitogen-activated protein kinase p38 and retinoblastoma protein signalling is required for DNA damage-mediated formation of senescence-associated heterochromatic foci in tumour cells. | 2013 Sep |
1 |
| 7 |
20594292 | Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. | 2010 Jul 1 |
1 |
| 8 |
19174488 | Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma. | 2009 Feb 15 |
6 |
| 9 |
19550397 | Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin. | 2009 Jun |
1 |
| 10 |
15141020 | Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. | 2004 May |
1 |
| 11 |
11289134 | Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity. | 2001 Mar 15 |
3 |
| 12 |
8033054 | The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients. | 1994 Jul 15 |
1 |